7,729 reports of this reaction
5.8% of all SILDENAFIL reports
#1 most reported adverse reaction
DYSPNOEA is the #1 most commonly reported adverse reaction for SILDENAFIL, manufactured by ANI Pharmaceuticals, Inc.. There are 7,729 FDA adverse event reports linking SILDENAFIL to DYSPNOEA. This represents approximately 5.8% of all 132,502 adverse event reports for this drug.
SILDENAFIL has an overall safety score of 85 out of 100. Patients taking SILDENAFIL who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is moderately reported among SILDENAFIL users, representing a notable but not dominant share of adverse events.
In addition to dyspnoea, the following adverse reactions have been reported for SILDENAFIL:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 7,729 FDA reports for SILDENAFIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 5.8% of all adverse event reports for SILDENAFIL, making it one of the most commonly reported side effect.
If you experience dyspnoea while taking SILDENAFIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.